Teriparatide · 2022-11-29
ClinicalTrials.gov record NCT01796301
Completed at observation.
Open attributed record →ClinicalTrials.gov registry-update year
2022 peptide clinical trials
27 selected ClinicalTrials.gov records carrying a 2022 registry-update date. This is selective historical coverage, not a complete trial inventory or an assessment of study quality.
Registry records
27 selected records.
Peptide profiles
10 connected profiles.
Completed at observation
25 retained records.
Attributed registry records
Selected records
Liraglutide · 2022-11-25
ClinicalTrials.gov record NCT03479762
Completed at observation.
Open attributed record →Liraglutide · 2022-11-17
ClinicalTrials.gov record NCT05153590
Completed at observation.
Open attributed record →Glucagon · 2022-11-04
ClinicalTrials.gov record NCT04042142
Completed at observation.
Open attributed record →Leuprolide · 2022-10-18
ClinicalTrials.gov record NCT02064036
Completed at observation.
Open attributed record →Lanreotide · 2022-10-14
ClinicalTrials.gov record NCT00774930
Completed at observation.
Open attributed record →Tesamorelin · 2022-09-30
ClinicalTrials.gov record NCT00608023
Completed at observation.
Open attributed record →Exenatide · 2022-09-16
ClinicalTrials.gov record NCT03456687
Completed at observation.
Open attributed record →Glucagon · 2022-09-06
ClinicalTrials.gov record NCT03255629
Completed at observation.
Open attributed record →Octreotide · 2022-08-04
ClinicalTrials.gov record NCT01229943
Completed at observation.
Open attributed record →Leuprolide · 2022-08-04
ClinicalTrials.gov record NCT02716974
Completed at observation.
Open attributed record →Glucagon · 2022-08-03
ClinicalTrials.gov record NCT02748369
Completed at observation.
Open attributed record →Leuprolide · 2022-07-26
ClinicalTrials.gov record NCT04225221
Completed at observation.
Open attributed record →Glucagon · 2022-06-28
ClinicalTrials.gov record NCT04007809
Current at observation.
Open attributed record →Leuprolide · 2022-06-21
ClinicalTrials.gov record NCT02770391
Completed at observation.
Open attributed record →Exenatide · 2022-06-07
ClinicalTrials.gov record NCT00775684
Completed at observation.
Open attributed record →Octreotide · 2022-05-23
ClinicalTrials.gov record NCT02010385
Completed at observation.
Open attributed record →Octreotide · 2022-05-13
ClinicalTrials.gov record NCT03520569
Completed at observation.
Open attributed record →Exenatide · 2022-05-05
ClinicalTrials.gov record NCT02664441
Completed at observation.
Open attributed record →Leuprolide · 2022-04-19
ClinicalTrials.gov record NCT02268175
Completed at observation.
Open attributed record →Liraglutide · 2022-04-12
ClinicalTrials.gov record NCT02765399
Completed at observation.
Open attributed record →Teriparatide · 2022-04-01
ClinicalTrials.gov record NCT00754442
Completed at observation.
Open attributed record →Lanreotide · 2022-03-16
ClinicalTrials.gov record NCT03158090
Current at observation.
Open attributed record →Semaglutide · 2022-01-19
ClinicalTrials.gov record NCT03548987
Completed at observation.
Open attributed record →Leuprolide · 2022-01-18
ClinicalTrials.gov record NCT03085095
Completed at observation.
Open attributed record →Leuprolide · 2022-01-10
ClinicalTrials.gov record NCT02122198
Completed at observation.
Open attributed record →Setmelanotide · 2022-01-04
ClinicalTrials.gov record NCT03262610
Completed at observation.
Open attributed record →